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Co-transmission of acetylcholine and GABA
regulates hippocampal states
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The basal forebrain cholinergic system is widely assumed to control cortical functions via
non-synaptic transmission of a single neurotransmitter. Yet, we find that mouse hippocampal
cholinergic terminals invariably establish GABAergic synapses, and their cholinergic vesicles
dock at those synapses only. We demonstrate that these synapses do not co-release but co-
transmit GABA and acetylcholine via different vesicles, whose release is triggered by distinct
calcium channels. This co-transmission evokes composite postsynaptic potentials, which are
mutually cross-regulated by presynaptic autoreceptors. Although postsynaptic cholinergic
receptor distribution cannot be investigated, their response latencies suggest a focal, intra-
and/or peri-synaptic localisation, while GABAA receptors are detected intra-synaptically. The
GABAergic component alone effectively suppresses hippocampal sharp wave-ripples and
epileptiform activity. Therefore, the differentially regulated GABAergic and cholinergic co-
transmission suggests a hitherto unrecognised level of control over cortical states. This novel
model of hippocampal cholinergic neurotransmission may lead to alternative pharma-
cotherapies after cholinergic deinnervation seen in neurodegenerative disorders.
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The cholinergic system arising from the basal forebrain
1,2
has a fundamental role in controlling cortical functions
including attention3, learning and memory4, plasticity5,
sleep–wake alternation6, and is implicated in neurodegenerative
diseases7.
Contemporary models of the basal forebrain cholinergic system
and efforts to develop pro-cholinergic treatments have been based
largely on the assumption that cholinergic cells release only a
single transmitter and it is released non-synaptically8–13. The
seemingly rare synapses on cholinergic fibres (see Supplementary
Discussion) supported the concept of non-synaptic transmission.
However, highly precise cholinergic transmission during reward
and punishment14, recordings of phasic release10,15,16, and the
dependence of hippocampal synaptic plasticity on the
millisecond-scale timing of the cholinergic input17 challenge this
textbook model of non-synaptic transmission by cholinergic
fibres.
Therefore, we hypothesised that all cholinergic terminals
establish synapses. After immunolabeling, we analysed the real
incidence of synapses, localised vesicle pools using STORM super-
resolution imaging and we also localised membrane-docked
neurotransmitter vesicles using electron tomography. Because
previous data suggested the co-localisation of acetylcholine and
GABA in retina and other brain areas18–23, we also hypothesised
that hippocampal cholinergic fibres may be GABAergic as well.
Using immunolabelling and optogenetics combined with in vitro
electrophysiology, we investigated the possible presence and sub-
cellular regulation of hippocampal co-transmission of acetylcho-
line and GABA, and the role of its GABAergic component in
controlling hippocampal network activity.
Challenging a decades-old model, we show that all hippo-
campal cholinergic terminals establish GABAergic synapses,
where cholinergic vesicles are released as well, and these synapses
evoke composite (hyperpolarising and depolarising) postsynaptic
potentials. Our data suggest synaptic release and action of GABA
and synaptic release and a focal, synaptic and/or peri-synaptic
action of acetylcholine. GABA and acetylcholine transmissions
are modulated by distinct calcium channels and were mutually
regulated by presynaptic autoreceptors. We demonstrate here that
synaptic release of GABA from cholinergic terminals alone can
suppress hippocampal sharp wave-ripples effectively and it can
attenuate hippocampal epileptiform activity as well.
Our data urge the re-interpretation of previous studies about
the basal forebrain cholinergic system and offer a new explana-
tion for the emergence of hippocampal epileptiform activity
associated with Alzheimer’s disease-related loss of cholinergic
innervation.
Results
All hippocampal cholinergic axon terminals form synapses.
Previous studies concluded that few cholinergic terminals form
synapses (see Discussion and Supplementary Discussion). We
hypothesised that all cholinergic terminals form synapses. By
identifying synapses with neuroligin 2 (NL2) labelling (Fig. 1,
Supplementary Figure 124,) on cholinergic fibres, we could test
the incidence of synapses with three-dimensional serial electron
microscopic reconstructions in the hippocampus. We recon-
structed randomly selected, long axonal segments [6–33 µm,
average: 21 µm, n= 17, labelled either with anti-choline acetyl-
transferase (ChAT) antibody in wild-type (WT) mice or with
eYFP-adeno-associated viruses (AAV) injected in ChAT-Cre
mice, Fig. 1, Supplementary Figure 1, Supplementary Table 4, for
controls see Supplementary Note 7 and Supplementary Figure 2]
and identified their synapses with NL2 or gephyrin immunogold
labelling. All of them established synapses abundantly (Fig. 1,
Supplementary Figure 1, Supplementary Note 1). The average
density of synapses was 42 synapses/100 µm. Some of these
contact sites would not have been considered synapses earlier,
because of their weak membrane thickening and narrower
intercellular synaptic gap (e.g. Figure 1a, synapse 2–3);24 however,
NL2 and gephyrin labelling clearly identified their active zones.
For comparison, we have also reconstructed GABAergic axonal
segments (labelled for cannabinoid receptor type-1, CB1; n= 2,
18 and 29 µm, Supplementary Figure 1, Supplementary Table 4),
which are known to establish synapses abundantly. Having ver-
ified that all hippocampal cholinergic terminals originate from
basal forebrain cholinergic cells (for controls see Supplementary
Note 7 and Supplementary Figure 2), we found that practically all
hippocampal cholinergic terminals examined established one or
more NL2-positive synapses (Fig. 1, Supplementary Figure 1;
Supplementary Table 4, Supplementary Note 1). As a con-
sequence, the linear density of synapses along cholinergic axons
was similar to that along GABAergic axons (Supplementary
Figure 1, Supplementary Table 4, number of synapses per 100 µm
cholinergic axons: 42 in CA1, 40 in S1, number of synapses per
100 µm CB1-positive axons: 51).
Using electron microscopy in hippocampal CA1, we found that
NL2 and gephyrin positive cholinergic synapses (n= 107,
collected from four mice) predominantly innervated pyramidal
dendritic shafts (63%) and spine-necks (27%), and they also
innervated interneuron dendrites (5%), while some (6%) post-
synaptic targets could not be classified (Fig. 1o, Supplementary
Table 4).
All innervated spines received another, putatively glutamater-
gic asymmetric, type-I input from an unlabelled terminal,
suggesting that, contrary to previous suggestion25, cholinergic
synapses alone do not induce spine formation. These data suggest
that about 90% of these synapses target pyramidal cells in CA1,
whereas they also innervate interneurons (at least 5%), which
ratio is close to the neuronal ratios in CA1.
We tested whether these synapses are GABAergic as well. First,
we localised the elements of postsynaptic GABAergic signalling
machinery in these contacts. We localised gephyrin first, because
it is known to interact with both GABAA receptors and NL2. We
found, that at least 81% of synapses on hippocampal cholinergic
fibres contained gephyrin postsynaptically, on dendrites and
spine-necks (Fig. 1, Supplementary Note 2, Supplementary
Table 3). In addition, we found that at least 80% of these
synapses showed GABAA receptor gamma2 subunit labelling that
was also readily detected on both dendrites and spine-necks
(Fig. 1, Supplementary Figure 1, Supplementary Table 3, and
Supplementary Note 2).
Then, we localised the elements of presynaptic GABAergic and
cholinergic signalling machinery in these terminals. By crossing a
zsGreen fluorescent reporter mouse-line with a vesicular GABA
transporter (vGAT)-Cre mouse line and labelling the medial
septum for ChAT, we found that all septo-hippocampal
cholinergic cells are also vGAT positive (Fig. 2a, b, Supplemen-
tary Note 3). Hippocampal cholinergic terminals expressed the
GABA-synthesising enzyme, glutamate decarboxylase 65
(GAD65) as well (Supplementary Note 3, Fig. 2c). In addition,
at least 83% of cholinergic septo-hippocampal terminals were
vGAT positive (Fig. 2d, Supplementary Note 3), whereas vesicular
acetylcholine transporter (vAChT) was detected in 64% of the
septo-hippocampal cholinergic terminals (Supplementary Note 4,
5). Finally, using postembedding immunogold staining,
we showed that GABA is detectable in cholinergic terminals
(Fig. 2e, f, Supplementary Note 3).
Composite GABAergic–cholinergic postsynaptic responses. We
investigated the electrophysiological properties of these
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cholinergic responses in target neurons. We injected Cre-
dependent, channelrhodopsin-2 (ChR2) expressing adeno-
associated virus (AAV-ChR2) into the medial septum of ChAT-
Cre knock-in mice (Fig. 3a, see Methods) and recorded
hippocampal cells. AAV-ChR2 labelled only cholinergic cells in
the septo-hippocampal pathway (see Supplementary Note 7) and
cells of wild-type mice did not respond to illumination, proving
that membrane potential responses in ChAT-Cre mice were
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Fig. 1 All cholinergic terminals establish synapses, express GABAergic markers and innervate pyramidal cells or interneurons. a Three-dimensional EM
reconstructions show that hippocampal cholinergic fibres form synapses (arrows) frequently. Axon A is labelled for ChAT in a WT mouse. Axon B is an
AAV-eYFP virus-labelled septo-hippocampal fibre in a ChAT-Cre mouse. Insets show two typical terminals with synapses (blue). The plasma membrane
was made partially transparent to reveal mitochondria (mito, green). Gold labellings of NL2 (axon A, synapse 1–4) or gephyrin (axon B, synapse 5–7) were
used to recognise synapses (black dots and arrows in the insets). EM images show terminal boutons (b) of the reconstructed axonal segments establishing
synapses 1–7 (arrowheads, indicated by the same numbers on the left) on dendrites (d) and a spine (s). Next to synapse 1, a ChAT-negative, putative
GABAergic terminal bouton (bneg) forming a NL2-positive synapse (arrow) is also shown. b–n EM images reveal the presence of gephyrin (arrowheads,
gold; b–d; g–j) and GABAA γ2 receptor subunits (arrowheads, gold; e–f; k–n) postsynaptically in synapses established by vAChT-positive terminals in WT
mice (b–f; DAB, b) or by AAV-eYFP-labelled septo-hippocampal terminals in ChAT-Cre mice (g–n; DAB, b). Images of consecutive sections are separated
by thin black lines. Terminals innervate dendrites (d) or spines (s). In j, the postsynaptic target is an interneuron dendrite (INd) that receives type-I
synapses as well (arrows). Synapses are from str. ori. (a, b–e, g–j, l,m), str. rad. (k, n) and str. l-m (f). Scale bar is 200 nm for all EM images. o Postsynaptic
target selectivity of reconstructed cholinergic axonal segments from str. oriens and radiatum. Spine: 27.1%, pyramidal cell dendrite: 62.6%, interneuron
dendrite: 4.7%, unidentifiable: 5.6%. p Comparison of the number of synapses per 100 µm cholinergic axonal segments in CA1 and S1 cortex and
GABAergic fibres in CA1
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caused only by cholinergic fibres. NMDA- and AMPA-type glu-
tamate receptors were blocked to prevent polysynaptic recruit-
ment of neuronal activity in all in vitro recordings presented in
Fig. 3.
We recorded the membrane potential of inhibitory neurons in
CA1 str. lacunosum-moleculare, because they are known to
display cholinergic responses26. Cells were recorded using whole-
cell patch-clamp in responses to 1 ms optical stimulation (Fig. 3a)
that resulted in a composite membrane potential response: a
GABAA receptor-dependent hyperpolarization (peak @ 13.8 ms),
and a slightly delayed (peak @ 92ms) acetylcholine receptor-
dependent depolarisation (Fig. 3c–e, Supplementary
Figure 3A–C). Although these synaptically released transmitters
may act on non-synaptic receptors as well, both responses had
relatively short onset latency (2.8 and 7.4 ms, Supplementary
Figure 3A–C) compared to typical non-synaptic transmission that
has a typical evoked onset latency of about 60–160ms27. Together
with our anatomical data these suggest synaptic release and action
of GABA and synaptic release and a very focal, synaptic and/or
peri-synaptic action of acetylcholine. Synaptic spill-over of GABA
and acetylcholine may act extrasynaptically as well.
Next, we blocked both nicotinic and muscarinic acetylcholine
receptors (AChR) and recorded inhibitory postsynaptic currents
(IPSC) on pyramidal cells (PCs) and interneurons (INs) after
optical stimulation of cholinergic fibres (Fig. 3f–i). Single IPSC
kinetics and short-term plasticity in PCs and INs were tested using
five short light pulses at physiologically relevant firing rates (at
2, 5, 10 and 20 Hz) measured in vivo28,29. The amplitude of the
evoked inhibitory currents (calculated for the first stimulus) was
larger on INs than on PCs, but their rise time (20–80%) was not
significantly different. IPSCs evoked in INs had a shorter decay
time (Fig. 3h). The series of light pulses revealed strong short-
term depression (STD) of inhibitory currents onto both PCs and
INs (Fig. 3g, i). GABAergic STD was observed in every tested
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Fig. 2 Cholinergic cells express the molecular machinery required for GABA release. a, b The cholinergic neurons of the MS are GABAergic. White box in
a contains area enlarged in b. Images show neurons stained for ChAT in red, while the green labelling marks the vGAT-expressing neurons in vGAT-ZsGreen
reporter mouse. c, d AAV-eYFP virus-traced septo-hippocampal fibres express GAD65 (c). AAV-eYFP virus-traced septo-hippocampal fibres express vGAT
and vAChT (d). Insets show xz and yz projections of the terminal labelled with an arrow. Arrowhead points to another terminal. Green line marks the fibre
outline. (Scale bar on d is 210, 14, 2 and 1 μm for a, b, c and d, respectively.) e, f Hippocampal cholinergic terminals contain GABA. Three consecutive EM
sections of a vAChT-positive terminal (e, red pseudocolor) are shown. vAChT was visualised by pre-embedding immunogold method (the first panel of e, silver-
intensified gold particles, large arrows), whereas on the next ultrathin sections (the second and third panels of e) postembedding GABA immunostaining was
performed (smaller gold particles, thin arrows, some GABA molecules penetrate into mitochondria during fixation). vAChT signal is absent in postembedding
images, because of the etching procedure. Scale bar is 200 nm for all EM images. f Cholinergic terminals contained significantly higher immunogold signal than
glutamatergic ones (p < 0.05) suggesting the presence of GABA in cholinergic terminals (median and interquartile ranges, Supplementary Note 8)
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neuron and was accompanied by a decrease in transmission
probability during the stimulation sequence (Supplementary
Figure 3), suggesting a presynaptic mechanism for STD.
Calcium influx through ChR2 expressed on axon terminals can
alter intrinsic short-term plasticity of the synapses30. To exclude
this possibility, we used a digital micro-mirror device (DMD)
inserted into the optical path of the microscope, to illuminate
cholinergic axons running towards the recorded cell, but not the
terminals (Supplementary Figure 3D). This resulted in STD
similar to that recorded with optic fibre illumination (Supple-
mentary Figure 3E–F), excluding the possibility of ChR2-
mediated Ca2+ influx, as the reason for the observed STD. A
series of stimuli could also decrease the driving force of chloride
through GABAARs, resulting in apparent STD31,32. In this case,
the putative site of STD would be postsynaptic instead of
presynaptic. When we used a high Cl− intracellular solution to
prevent shifts in Cl- reversal, a series of stimuli resulted in STD
similar to that shown above (Supplementary Figure 3G and H).
Cholinergic and GABAergic vesicle docking is restricted to
synapses. Our physiological and anatomical data showed that
cholinergic terminals establish synapses. Non-synaptic
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Fig. 3 Optogenetic stimulation of cholinergic fibres elicits composite GABAergic and cholinergic postsynaptic responses. a Medial septum (MS) of ChAT-
Cre mice were injected with Cre-dependent AAV containing Channelrhodopsin-2 (ChR2). Using whole-cell patch-clamp in horizontal hippocampal slices,
we recorded voltage or current response from hippocampal neurons upon optical excitation of septo-hippocampal cholinergic fibres. NMDA and AMPA
receptors were blocked with AP5 (50 µM) and NBQX (20 µM) in all experiments presented in Figs. 3 and 5. b Representative post-hoc visualised CA1
pyramidal cell (magenta) and the surrounding cholinergic fibres (green) with putative contacts (inset, white arrowheads). c Blue light pulses elicited a
composite membrane potential response from str. lacunosum-moleculare inhibitory neurons (green, average of 50 stimulations). Inhibition of GABAARs
(10 µM gabazine) abolishes the hyperpolarising component (nine from nine tested cells), resulting in a putative cholinergic excitatory potential (black).
Inhibition of all AChRs (1 µM MLA, 1 µM DHβE, 10 µM atropine, four from four tested cells) blocks the remaining depolarising response (magenta).
d Conversely, first blocking the AChRs, resulted in a putative GABAergic IPSP (magenta), which was blocked by GABAARs inhibitor gabazine (black). The
increase of IPSP amplitude for AChR block is addressed in Fig. 5. e Magnified cholinergic EPSP (black) from c, and GABAergic IPSP from d (magenta)
demonstrate their short latency (see also Supplementary Figure 3). f A representative recorded pyramidal cell (PC, top) and an inhibitory neuron (IN,
bottom) post-hoc visualised in magenta and ChR2 positive cholinergic axons in green. Insets: Immunostaining for gephyrin (white) identify their putative
synapses (white arrows). g We blocked both nicotinic and muscarinic AChRs (1 µM MLA, 1 µM DHβE, 10 µM atropine) and recorded inhibitory
postsynaptic currents (IPSC) evoked by cholinergic fibre illumination. Traces show IPSC response of a PC and an IN to five light pulses (1 ms) at increasing
stimulation frequencies (2, 5, 10, 20 Hz, cells were recorded in VC@0mV). h Amplitude and decay time of unitary GABAergic IPSCs from pyramidal cells
(n= 5) and inhibitory neurons (n= 16) were statistically different (p < 0.05), while their rise time was not different (median values, interquartile ranges
and min/max values, see Supplementary Note 8). i Averages of IPSC amplitudes for the five pulses presented on g shows strong short-term depression
(STD) of GABAergic transmission evoked by stimulating cholinergic fibres (for details see Supplementary Note 8 and Supplementary Figure 3)
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acetylcholine release, however, might still be possible, if choli-
nergic vesicles could be docked and fused outside of the synaptic
active zones as well. Using advanced electron tomography tools,
we were able to reconstruct cholinergic fibre segments, to localise
vesicles with 1 nm resolution and to analyse the precise dis-
tribution of synaptic vesicles in hippocampal cholinergic term-
inals. We identified terminals using vAChT immunogold
labelling and reconstructed them using electron tomography
(Fig. 4a–d). Three-dimensional reconstruction revealed that
synaptic vesicles clustered close to the active zones (Fig. 4d). We
measured the distances of vesicles to the closest (synaptic or non-
synaptic) cell membranes, and compared their density at different
distance intervals from the membranes (Fig. 4f). The density of
the vesicles within 60 nm from the membranes was 6.5 times higher
in the synaptic active zone than extrasynaptically (Fig. 4d, f). We
did not find any docked (<5 nm from the membrane) or fused
(undergoing exocytotic fusion) vesicles non-synaptically, but we
detected both of these at synapses (Fig. 4b, c, f). The distribution
of vesicles in cholinergic terminals was similar to that found at
other glutamatergic or GABAergic terminals, arguing against
non-synaptic vesicular docking or release in cholinergic
terminals.
Vesicular volume can correlate with its transmitter content33.
Therefore, using electron tomography, we compared the vesicular
morphology between cholinergic and GABAergic terminals
(Fig. 4e). Vesicles of cholinergic terminals were significantly (p
< 0.001), about 60% larger than those in GABAergic terminals
(Fig. 4e, Supplementary Note 4) and their volumes were
significantly more variable as well (p < 0.001). Smaller (putatively
GABAergic) vesicles of cholinergic terminals were similar to
those in purely GABAergic terminals (Fig. 4e, see Supplementary
Note 4), suggesting an even larger difference between the two
types of vesicles.
Acetylcholine and GABA in different vesicles and same vesicle
pool. To further confirm that the two transmitter systems use the
same active zones, we used confocal fluorescent imaging in mouse
hippocampus and found that vAChT-positive vesicles were con-
centrated at gephyrin-labelled synapses (Fig. 4g, h, Supplemen-
tary Note 5). Scale-free analysis confirmed that the likelihood of
vAChT labelling was the highest at the gephyrin-labelled synaptic
active zones (Fig. 4i, Supplementary Note 5).
Using super-resolution STORM imaging of vGAT and vAChT
immunolabelling, combined with correlated fluorescent confocal
laser-scanning microscopy (CLSM) of cholinergic fibres, we
demonstrated that cholinergic–GABAergic vesicle pools were
mixed and were confined to a small volume of the AAV-eYFP-
labelled septo-hippocampal terminals (Fig. 4j, Supplementary
Note 5).
Using isolated mouse cortical synaptic vesicles (neocortex and
hippocampus, in ~4:1 ratio), we found that acetylcholine and
GABA are packed into different vesicles (Supplementary
Figure 4A, Supplementary Note 6). Both flow cytometry
(Supplementary Figure 4B) and electron microscopy data
(Supplementary Figure 4C, E) confirmed the purity of our
sample (see also Supplementary Note 6 and Methods). All vesicles
were labelled with synaptophysin (SYP). After quadruple-
immunolabelling of the isolated synaptic vesicles, 29% were only
SYP-positive, 45% were double labelled for vesicular glutamate
transporter 1 and SYP, 14% were double labelled for vGAT and
SYP, 11% were double labelled for vAChT and SYP. Only a
negligible amount of vesicles (0.9%) were triple labelled with any
combinations and only 0.14% of all vesicles were co-labelled for
vAChT and vGAT, suggesting that vesicular transporters for
GABA and acetylcholine are expressed by distinct vesicle
populations in cortical samples (Supplementary Figure 4H;
Supplementary Note 6).
Different Ca-channel and mutual autoreceptor modulation.
Our anatomical data indicated that acetylcholine and GABA are
stored in, and thus likely released from different vesicles. First, we
investigated presynaptic modulation of this vesicular release.
Blocking AChRs increased the amplitude of GABAergic hyper-
polarization (Fig. 3d), for which presynaptic muscarinic receptors
may be responsible26. We held CA1 interneurons at −50 mV, to
record GABAergic hyperpolarization and cholinergic depolar-
isation concurrently (Fig. 5a, NMDA- and AMPA-type glutamate
receptors were blocked to prevent polysynaptic recruitment of
neuronal activity in all in vitro recordings presented in Fig. 5).
Muscarinic receptor blocker atropine (10 µM) significantly
increased the amplitude of both GABAergic IPSPs and choli-
nergic EPSPs (Fig. 5b). By blocking M2-type AChRs, reported
abundant in hippocampal cholinergic terminals26,34, we repro-
duced PSP increases evoked by atropine (Fig. 5c). This confirms
the role of M2-type AChRs in regulating both acetylcholine and
GABA release from cholinergic terminals.
Previously, we described the presence of presynaptic GABAB
autoreceptors in septal cholinergic cells35. To test their role in
regulating synaptic co-transmission, we blocked GABAB recep-
tors. This led to a significant increase in the amplitude of both
GABAergic IPSPs and cholinergic EPSPs (Fig. 5d). However, we
did not see GABAB receptor-dependent postsynaptic hyperpolar-
ization in response to cholinergic fibre stimulation in our
recordings. Overall, these experiments revealed that GABA and
acetylcholine cross- and auto-regulate their co-transmission from
cholinergic–GABAergic terminals, presynaptically.
Dynamics of vesicle release likely depends on the type of
voltage-dependent calcium channels (VDCCs), which mediate
Ca2+-triggered vesicle release36. However, different VDCCs in
the same cell20 can be associated with distinct types of vesicles.
Indeed, we found that selective blockade of P/Q-type calcium
channels decreased GABAergic IPSPs significantly, but caused no
change in the cholinergic components (Fig. 5e). Conversely, the
cholinergic component was robustly decreased after the selective
blockade of N-type calcium channels, while GABAergic IPSPs
showed no significant change (Fig. 5f). Besides confirming the
presence of different vesicular pools, this revealed different
molecular pathways for their regulation during co-transmission.
Distinct vesicle pools of the same terminals can couple to
different release mechanisms with different short-term plasti-
city20. Because GABAergic transmission always showed strong
STD in cholinergic terminals (Fig. 3g, i), we examined, whether
cholinergic responses display similar short-term dynamics. We
recorded inhibitory neurons in the physiologically relevant
current clamp (I= 0) situation, and repeatedly light-stimulated
ChR2-expressing cholinergic axons (Supplementary Figure 3J).
The net depolarisation for a series of five stimuli did not decrease.
Also, the area under the voltage curve increased with frequency
(Supplementary Figure 3J–K). In current clamp (more than in
voltage clamp) even a non-depressing transmission could be seen
as depressing due to reduction of driving force. Therefore, based
on our current clamp measurements, it is highly unlikely that the
cholinergic component would show such a strong STD as the
GABAergic component.
GABA release of cholinergic cells shape hippocampal states.
Septal cholinergic neurons control hippocampal activity
states37,38 and suppress in vivo sharp wave-ripples (SWR) in the
hippocampus39. However, the effect of their hippocampal GABA
release has not been investigated. We recorded spontaneous
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Fig. 4 Separate vesicular release of acetylcholine and GABA from the same synaptic active zones. a–c About 0.5 nm-thick virtual sections from electron
tomographic reconstructions of cholinergic terminals. Terminal is orange, mitochondria are yellow, synaptic vesicles are blue. Black arrowheads point to the
edges of the synapse. Scale bar is 200 nm. b Active zone is enlarged from a. The omega-shaped vesicle is being fused with the terminal membrane (blue
arrowhead). c Two serial virtual sections showing a portion of the active zone of another terminal. A fused synaptic vesicle (blue arrowhead) is labelled for
vesicular acetylcholine transporter (black immunogold particle). Scale bar for b and c is 100 nm. d Three-dimensional models of reconstructed terminals.
Terminal membranes are orange, mitochondria are yellow, synaptic vesicles are blue and synapses are green. Green arrows point to the synapses. Scale
bar is 200 nm. The association of the vesicle pools to the active zones is evident. e Scatterplot shows the relationship of vesicle size (volume) and
elongation factor in the sampled vesicles. Vesicles in the cholinergic terminals had a broader size-distribution than vesicles of purely GABAergic terminals,
which were smaller and more elongated (Supplementary Note 4). Some vesicles (black markers) could be identified as vAChT-positive because
immunogold particles clearly labelled them. f The density of the vesicles within a 60-nm-wide band from the membrane is plotted as a function of distance
from the terminal membrane at synaptic (green) and extra-synaptic (black) areas. Vesicle density was 6.5 times higher (in the first 60 nm from the
membrane) in the synaptic active zone than extrasynaptically (n= 183 vesicles from 8 terminals in 2 mice). Docked (closer to the membrane than 5 nm) or
fused (undergoing exocytotic fusion) vesicles were absent extrasynaptically, but were present in the active zones. g, h vAChT labelling was confined to
synaptic active zones in cholinergic fibres. CLSM images show terminals of virus-traced septo-hippocampal fibres (red pseudocolor) containing vAChT-
positive vesicle pools (yellow), localised to the synaptic active zones that are identified by gephyrin labelling (blue). Scale bar is 500 nm for g and h. i Scale-
free analysis confirms that the likelihood of vAChT labelling is the highest at the synaptic active zones (n= 32 synapses, 2 mice). j Correlated CLSM-
STORM super-resolution microscopy images show that vAChT (yellow) and vGAT (cyan) vesicle pools are overlapping and are confined to small portions
within AAV-eYFP virus-traced septo-hippocampal fibres (red pseudocolor)
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SWRs in hippocampal slices (Fig. 6, Methods). Illumination of
control slices without ChR2 expression caused no change in SWR
activity. In AAV-ChR2-infected ChAT-Cre mice, we found that
without blocking cholinergic transmission, optical stimulation of
cholinergic fibres decreased SWR rate significantly (Fig. 6c, d),
followed by a transient increase in SWR rate after the cessation of
optical stimuli. However, when cholinergic transmission was
blocked, the same optical stimulation caused a similar decrease in
SWR rate (Fig. 6e, f), with no rebound after stimulation. Although
cholinergic fibres have been reported to be responsible for inhi-
biting SWRs39, here we demonstrated that GABA release from
cholinergic synapses alone is sufficient to downregulate the rate of
SWRs.
The GABA release from septo-hippocampal cholinergic fibres
may also affect the occurrence of hippocampal epileptiform
activity. Therefore, we examined the effect of GABA release from
cholinergic axons in the in vitro high potassium epilepsy model
(Fig. 6g–k)40,41. Optical stimulation of cholinergic fibres reduced
the rate of epileptiform events (Fig. 6h, i) and a similar reduction
was present, when AChRs were blocked (Fig. 6j, k). These results
demonstrated that synaptic transmission of GABA from choli-
nergic fibres alone can effectively control hippocampal epilepti-
form activity.
Discussion
Our results challenge the model of non-synaptic single trans-
mitter release from cholinergic fibres in the hippocampus and
demonstrate that all cholinergic terminals establish synapses,
where GABA and acetylcholine are released into the same
synaptic gap. Our results also show non-synaptic action of these
synaptically released transmitters. We showed that hippocampal
cholinergic terminals established effective GABAergic synapses as
well. Cholinergic fibres are among the densest and most influ-
ential subcortical pathways in hippocampus; therefore, our find-
ings suggest a fundamental change in our view of the regulation
of hippocampal states. We also found that acetylcholine and
GABA were not co-released but co-transmitted from the same
synaptic active zone. We confirmed this by showing that (i)
isolated cortical transmitter vesicles do not co-express vGAT and
vAChT, (ii) they are preferentially modulated by distinct voltage-
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Fig. 5 Co-transmission of GABA and acetylcholine is cross-regulated by autoreceptors and mediated by distinct calcium channels. a Optical stimulations of
cholinergic fibres trigger composite membrane potential responses (average of 50 traces) of an inhibitory neuron recorded in str. lacunosum-moleculare
(green). Cells were held at approximately −50 mV to record hyperpolarising and depolarising components concurrently. Early hyperpolarization was
confirmed to be of GABAergic origin by bath application of the GABAAR blocker gabazine (magenta, 10 µM, which abolished quick hyperpolarization in 9
out of 9 tested cells), while the late depolarisation was confirmed to be cholinergic by the application of the alpha4-type nicotinic acetylcholine receptor
blocker DHβE (black, 1 µM, which abolished depolarisation in 5 out of 5 tested cells). Cells with identifiable nicotinic responses were used to further
investigate the properties of GABA and acetylcholine release from cholinergic fibres. b Increase in GABAergic response after AChR block (Fig. 3d)
suggested that presynaptic muscarinic receptors cross-modulated GABA (and possibly ACh) release from cholinergic fibres. Therefore, putative
presynaptic muscarinic receptors were selectively inhibited via bath application of atropine (n= 6), which led to a significant increase in amplitude of both
the GABAergic hyperpolarization and nicotinic depolarisation (green, see Supplementary Note 8). c Bath application of the selective M2 antagonist AFDX-
116 (10 µM, n= 6) resulted in changes similar to that of atropine application (for data see Supplementary Note 8). d Blocking GABABRs with CGP-55845
(1 µM, n= 7) also resulted in increased GABAergic and cholinergic responses suggesting a dual modulatory role (for data see Supplementary Note 8).
e, f Testing roles of distinct voltage-dependent calcium channels (VDCC) in release of GABA and ACh . e Blockade of P/Q-type VDCC, using selective
antagonist ω-agatoxin (1 µM, puff application), reliably decreased GABAergic response component but did not alter cholinergic component. At control
conditions, 5 short (1 ms) light pulses at 10 Hz evoked a composite event of GABAergic hyperpolarization and cholinergic depolarisation (green, average of
20 traces). In response to ω-agatoxin application (magenta, n= 9), the GABAergic component (measured as IPSP amplitude) decreased robustly
(magenta arrowhead) and the cholinergic component (measured as EPSP area) showed no change (for details see Supplementary Note 8). f Blockade of N-
type VDCC, using selective blocker ω-conotoxin (1 µM), reliably reduced cholinergic response component (n= 6) but left GABAergic component
unchanged (for details see Supplementary Note 4)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05136-1
8 NATURE COMMUNICATIONS |  (2018) 9:2848 | DOI: 10.1038/s41467-018-05136-1 | www.nature.com/naturecommunications
dependent calcium channels and (iii) electron tomography sug-
gested differences in the volume of GABA and acetylcholine
containing vesicles. This co-transmission (similar to that in
retina20) may require nanoscale sub-synaptic organisation of pre-
synaptic molecules, as proposed before42,43. Emphasising the
functional role of GABA release, we also demonstrated that
synaptic GABA release from cholinergic terminals alone can
effectively suppress hippocampal sharp wave-ripples and per se
can attenuate hippocampal epileptiform activity. These confirmed
the functional importance of this GABAergic–cholinergic co-
transmission in healthy and pathological states and led to a novel
model of the septo-hippocampal cholinergic neurotransmission.
For decades, the predominant form of cholinergic commu-
nication was thought to be a form of non-synaptic release8–10,12,44,
which was seemingly supported by studies showing cholinergic
fibres with few synapses (for details see Supplementary Discus-
sion). Originally, the presence of extra-synaptic acetylcholine
receptors and micro-dialysis experiments seemed to support a
non-synaptic release hypothesis; however, later, sensitive micro-
electrodes showed faster changes in extracellular acetylcholine
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Fig. 6 GABA release from cholinergic terminals controls healthy and pathological hippocampal network activity. a To understand the functional impact of
GABA and acetylcholine co-transmission onto cortical network oscillations, local field potential (LFP) was recorded with standard patch pipettes from the
CA1 area of thick hippocampal slices. These slices generated healthy and pathological in vivo like activity patterns. Cholinergic fibres expressing ChR2 were
illuminated with blue light in the presence, or in the absence of AChR blockers parallel with LFP recordings. b A spontaneous sharp wave-ripple (SWR) LFP
signature (bottom), and its wavelet transform (top) highlighting the characteristic ripple-band frequency component (~200 Hz, white arrowhead). c, d LFP
recording from hippocampal CA1 in the absence of AChR blockers (n= 9). Orange raster indicate SWR peaks for three consecutive stimulation periods.
Optical stimulation decreased SWR rate significantly (d), then SWR rate increased temporarily after the cessation of optical stimulation (median values,
interquartile ranges and min/max values, for data see Supplementary Note 8). e, f After we blocked AChRs (1 µM MLA, 1 µM DHβE, 10 µM atropine), LFP
recording from CA1 (n= 9) showed that GABA release from cholinergic fibres alone could decrease SWR rate even more effectively (f). There was no
SWR rate increase after the cessation of optical stimulation (median values, interquartile ranges and min/max values, for data see Supplementary Note 8).
g Epileptiform activity was evoked by elevating K+ concentration in the ACSF to 8.5 mM in slices. LFP (bottom) and its wavelet transform (top) shows the
signature of a pharmacologically evoked epileptiform events. Note the robust differences in amplitude, length and frequency components compared to
physiological SWR activity (Fig. 6b) that is consistent with literature data41. h, i Epileptic activity recorded in CA1 in the absence of AChR blockers (n= 7).
Orange raster indicate detected epileptic activity peaks for three consecutive stimulation periods. Illumination of cholinergic fibres reduced the rate of
epileptic events (i), which recovers after the cessation of optical stimulation (for data see Supplementary Note 8). j, k Epileptic activity recorded in CA1 in
the presence of AChR blockers (n= 8). Even in the presence of AChR blockers, illumination of cholinergic fibres reduced the rate of epileptic discharges
(k), which recovers after the stimulation (median values, interquartile ranges and min/max values, for data see Supplementary Note 8), suggesting a
crucial role for GABA release in controlling epileptiform activity
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levels (Supplementary Discussion). In addition, basal forebrain
cholinergic neurons were also shown to respond to reward and
punishment with extremely high speed and precision14, and
recent data suggested that cholinergic cells may regulate cor-
tical information processing with a remarkable, millisecond-
scale temporal precision15,17,45–48. These data urged the re-
examination of whether acetylcholine release is synaptic49. Using
electron tomography and direct labelling of synapses for neuro-
ligin 2, we showed that, all terminals of the dense meshwork of
hippocampal cholinergic fibres established (one or more)
synapses and no docked or fused vesicles were detectable non-
synaptically. Most of these synapses were missed previously,
probably, because of their weak membrane thickening and nar-
rower synaptic gap. Furthermore, we found that vAChT-labelled
vesicle pools associated only with synaptic active zones (Fig. 7).
Non-synaptic transmission has a typical delayed onset latency
of about 60–160 ms27, while synaptic onset latencies are typically
more than an order of magnitude faster. For instance, the average
latency with optogenetic stimulation can be as long as 6.450 or 5.6
ms51 for monosynaptic glutamate transmission. Our data show
the release of acetylcholine into the synaptic active zone and a 7.4
ms onset cholinergic response latency. These response latencies
suggest a focal, intra- and/or peri-synaptic localisation of nico-
tinic receptors, while GABAA receptors are detected intra-
synaptically. However, future work will be required to resolve
the contribution of intra- and/or peri-synaptic receptors to the
cholinergic response, because measured, relatively fast latency
alone cannot reveal the distribution of postsynaptic receptors
around synapses. Although none of our data suggests “volume
transmission” of acetylcholine or GABA, they may still act on
extra-synaptic receptors as well, in a “volume transmission”
fashion. In fact, the most likely resolution for the mismatch
between our and the classic non-synaptic volume transmission
hypothesis is a strong “spill-over” of transmitters from these
frequently occurring synapses that would allow transmitters to
reach extra-synaptic receptors as well. In fact, the much larger
cholinergic vesicles that we found could contain more acet-
ylcholine to counteract its effective extra-synaptic removal by
extracellular acetylcholine esterase.
Co-transmission can significantly increase the efficacy of
information transfer52–54. Using purified vesicle preparation, we
showed that GABA and acetylcholine are not “co-released” from
the same vesicles, but “co-transmitted” from separate vesicles,
sequentially inhibiting and exciting hippocampal neurons. To
unlock the full potential of co-transmission, these coexisting
vesicle pools need complex regulation. Indeed, we showed that
the release of GABAergic vesicles are preferentially regulated by
P/Q-type calcium channels, while the cholinergic ones are more
affected by N-type calcium channels in the same synapses (Fig. 7),
similar to that of retinal co-transmission of GABA and acet-
ylcholine20, therefore, an activity-dependent segregation in their
release is also possible. Under special circumstances one of these
transmitters may even be depleted earlier (GABAergic trans-
mission shows strong STD). Differential calcium channel reg-
ulation may be achieved by sub-synaptic nanoscale organisation
of presynaptic molecules42,43, while the presence of two different
kinds of presynaptic channel “slots” have already been suggested
at excitatory synapses: one accepting N-type channels but
rejecting P/Q-type (N-specific) and the other preferring P/Q-type
but also accepting N-type (PQ preferring53,).
Negative feedback via presynaptic autoreceptors could provide
a further level of control (Fig. 7). Previously, we demonstrated
that septo-hippocampal cholinergic neurons express GABAB-
receptors35, while the expression of muscarinic M2 receptors was
also described in these cells34. Indeed, we confirmed that blocking
either M2- or GABAB-receptors increased the release of both
acetylcholine and GABA, suggesting the presence of tonically
active autoreceptor regulation of these transmitters, pre-
synaptically. In addition, our results, verified by a series of control
experiments, suggested that GABAergic STD is an intrinsic
property of synapses established by cholinergic fibres in the
mouse hippocampus.
The timing of this co-transmission seems crucially important
in hippocampal Schaffer collateral (SC) to CA1 synaptic plasti-
city. If the cholinergic input was activated 100 or 10 ms before SC
stimulation, it resulted in ionotropic AChR-dependent long-term
potentiation (LTP) or short-term depression, respectively, while
delaying cholinergic stimulation until 10 ms after SC stimulation
resulted in metabotropic AChR-dependent LTP17. Here, we
found that the GABAergic and cholinergic components of this
co-transmission reach their IPSP and EPSP peak about 13.8 and
92 ms after stimulation, respectively, which suggest that synaptic
plasticity may depend on the coincidence of SC stimulation with
the GABAergic or cholinergic component of PSPs from these
basal forebrain fibres. Nevertheless, the GABAergic component
seems to have its own inhibitory role in the target network,
making basal forebrain cholinergic fibres an unorthodox but
effective source of GABAergic inhibitory control of the hippo-
campus, as suggested by our demonstration of its effect on net-
work dynamics.
Basal forebrain cholinergic cells play a pivotal role in trans-
forming activity states in the hippocampus37. High cholinergic
cell activity is associated with theta oscillation and the fast, yet
unstable storage of external information in the hippocampus,
while low cholinergic activity accompanies sharp wave-ripple
(SWR) activity55, which seems important for the consolidation
and relocation of unstable memory traces from the hippocampus
to the neocortex56,57. Classic theories of cholinergic modulation
presume that diffusely released acetylcholine would slowly retune
cortical network activity, enabling the appearance of distinct
network dynamics8,58,59. Indeed, a recent study demonstrated
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Fig. 7 Illustration of cholinergic terminals and their synaptic architecture.
Summary illustration of some of the findings. All cholinergic terminals
establish synapses, they are fully equipped with GABAergic–cholinergic co-
transmission signalling machinery. GABAergic and cholinergic vesicles are
regulated by different VDCCs. Although postsynaptic cholinergic receptor
distribution cannot be investigated, their response latencies (that are at
least and order of magnitude faster that typical non-synaptic transmission)
suggest a focal, intra- and/or peri-synaptic localisation, while GABAA
receptors are detected intra-synaptically. Synapses are established on both
dendritic shafts and spines in hippocampus
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that medial septal cholinergic cells suppress SWR activity
in vivo39. The authors suspected an M2 cholinergic receptor-
mediated suppression of GABAergic interneurons. We re-
examined that hypothesis and confirmed that cholinergic fibre
activation indeed suppressed SWRs; however, we also showed
that GABA (without acetylcholine) release from cholinergic fibres
alone was able to achieve that. This GABAergic inhibition could
lower the probability of concurrently active pyramidal cells in a
given time-window, which is required for stochastic SWR
initiation60. Blocking all GABA receptors would have eliminated
SWRs61, therefore the effect of acetylcholine release alone, with-
out the contribution of GABA co-transmission could not be
addressed. The presence of a transient increase in SWR rate after
the cessation of optical stimuli, might reflect longer-lasting
changes in network or cell excitability, mediated by “synaptic
spill-over” of acetylcholine, while the effect of GABA release from
smaller vesicles is likely confined to synaptic (and presynaptic)
receptors. However, this transient effect was not reported
in vivo39, therefore, it could have been the result of a relatively
low acetylcholine esterase activity in our dual-superfusion system.
Degeneration of the cholinergic system is a typical character-
istic of Alzheimer’s disease pathology7, and these patients often
develop epileptic seizures62. Indeed, selective lesion of medial
septal cholinergic projection increases seizure incidence in the
hippocampus63–65, while REM-sleep, which is associated with
enhanced cholinergic cell activity29, has a suppressing effect on
epileptic seizures66,67. The mechanisms, however, were unclear,
because several cholinergic agonists were shown to trigger epi-
leptic discharges68. Therefore, we hypothesise that degeneration
of basal forebrain cholinergic cells leads to epileptiform activity
primarily, because it deprives the hippocampus of a massive
GABAergic input. Indeed, our results supported this idea, because
GABA release from basal forebrain cholinergic fibres alone was
sufficient to decrease the occurrence of epileptiform activity in the
hippocampus.
Our results, showing a tightly regulated, effective, synaptic
GABA co-transmission from hippocampal cholinergic fibres urge
the re-interpretation of previous models and can lead to alter-
native pharmacotherapies to treat Alzheimer’s disease-related loss
of cholinergic innervation.
Methods
Animals and surgery. A total of 21 (25–80 days old) male C57BL/6J mice, 51
(30–200 days old) ChAT-IRES-Cre mice from either sex (Jackson Laboratory,
RRID: IMSR_JAX:006410, postnatal day 30–200) and 4 (30–50 days old) VGAT-
IRES-Cre/Gt(ROSA)26Sor_CAG/ZsGreen1 mice were used in the present study.
All experiments were performed in accordance with the Institutional Ethical
Codex, Hungarian Act of Animal Care and Experimentation (1998, XXVIII, sec-
tion 243/1998) and the European Union guidelines (directive 2010/63/EU), and
with the approval of the Institutional Animal Care and Use Committee of the
Institute of Experimental Medicine of the Hungarian Academy of Sciences. All
efforts were made to minimise potential pain or suffering and to reduce the
number of animals used.
ChAT-Cre mice were anaesthetised with isoflurane followed by an
intraperitoneal injection of an anaesthetic mixture (containing 8.3 mg/ml ketamine,
1.7 mg/ml xylazine-hydrochloride in 0.9 % saline, 10 ml/kg bodyweight) and then
were mounted in a stereotaxic frame. For selective labelling of septo-hippocampal
cholinergic axons, we injected 30–60 nl AAV2/5-EF1a-DIO-eYFP (UNC Vector
Core) or AAV2/5-EF1a-DIO-ChR2(H134R)-eYFP-WPRE-hGH (plasmid:
Addgene 20298, Penn Vector Core) into the medial septal area. The coordinates for
the injection were based on the atlas by Paxinos, G and Franklin, (2012)69: 1 mm
anterior from the bregma, in the midline, and 4.3 mm below the level of the
horizontal plane defined by the bregma and the lambda (zero level). For a control
experiment, 100 nl injections of the same virus were delivered into the
hippocampus (both hemispheres) of a ChAT-Cre mouse (coordinates: −2.7 mm
from the bregma, ±2.5 mm from the midline, 2.5 mm from the zero level and −3.1
from the bregma, ±3 mm from the midline and 3 mm from the zero level). For the
injections, we used a Nanoject 2010 precision microinjector pump (WPI, Sarasota,
FL 34240). We used borosilicate micropipettes (Drummond, Broomall, PA) for the
injections with tips broken to 40–50 µm. After the surgeries, the animals received
0.5–0.7 ml saline for rehydration and 0.03–0.05 mg/kg meloxicam as nonsteroidal
anti-inflammatory drug (Metacam, Boehringer Ingelheim, Germany)
intraperitoneally to support recovery, and we placed them into separate cages to
survive for at least three weeks before decapitations or perfusions.
Slice preparation and recording conditions. After 3–6 weeks following injection
(to reach an appropriate expression level in long-range projecting axons) hor-
izontal slices were prepared. In all cases, mice were decapitated under deep iso-
flurane anaesthesia. The brain was removed into ice-cold cutting solution, which
had been bubbled with 95% O2–5% CO2 (carbogen gas) for at least 15 min before
use. The cutting solution contained the following (in mM): 205 sucrose, 2.5 KCl, 26
NaHCO3, 0.5 CaCl2, 5 MgCl2, 1.25 NaH2PO4, 10 glucose, saturated with 95%
O2–5% CO2. Horizontal hippocampal slices of 300 µm or 450 µm thicknesses (for
whole-cell and LFP recordings, respectively) were cut using a vibratome (Leica
VT1000S). After acute slice preparation the slices were placed into an interface-
type holding chamber for recovery. This chamber contained standard artificial
cerebrospinal fluid (ACSF) at 35 °C that gradually cooled down to room tem-
perature. The ACSF had the following composition (in mM): 126 NaCl, 2.5 KCl, 26
NaHCO3, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 10 glucose, saturated with 95% O2–5%
CO2. After incubation for at least 1.5 h, slices were transferred individually into a
submerged-style recording chamber equipped with a single superfusion system. In
case of LFP recording of hippocampal network activities, a double superfusion
system was used for improved slices maintenance conditions60,70. In the latter
design, the slices were placed on a metal mesh and two separate fluid inlets allowed
ACSF to flow both above and below the slices with a rate of 3–5 ml/min for each
flow channel at 30–32 °C (Supertech Instruments; www.super-tech.eu). The com-
position of the modified ACSF (mACSF) used in experiment presented in Fig. 6g–k
was the following (in mM): 126 NaCl, 3.5 KCl, 26 NaHCO3, 1.6 CaCl2, 1.2 MgCl2,
1.25 NaH2PO4, 10 glucose saturated with 95% O2–5% CO2. Epileptic events were
evoked by further increasing the potassium concentration from 3.5 to 8.5 mM after
15 min spent in mACSF in the recording chamber. Slices were visualised with an
upright microscope (Nikon Eclipse FN1 or Olympus BX61WI) with infrared-
differential interference contrast optics. Standard patch electrodes were used in all
recording configurations (i.e., in whole-cell patch-clamp and field potential
recordings). Pipette resistances were 3–6 MΩ when filled either with the intra-
cellular solution or with ACSF. ACSF filled pipettes placed into CA1 pyramidal
layer were used for local field potential (LFP) recordings. The composition of the
intracellular pipette solution was the following (in mM): 110 K-gluconate, 4 NaCl,
20 HEPES, 0.1 EGTA, 10 phosphocreatine, 2 ATP, 0.3 GTP, 3 mg/ml biocytin
adjusted to pH 7.3–7.35 using KOH (285–295 mOsm/L). Where indicated, high-
chloride containing intracellular solution was used: 54 K-gluconate, 4 NaCl, 56
KCl, 20 HEPES, 0.1 EGTA, 10 phosphocreatine, 2 ATP, 0.3 GTP, 3 mg/ml biocytin
adjusted to pH 7.3–7.35 using KOH (285–295 mOsm/L). Whole-cell series resis-
tance was in the range of 5–15 MΩ. Series resistance was not compensated but was
frequently monitored, and cells where the values changed more than 25% during
recording were discarded from further analysis. Voltage measurements were not
corrected for the liquid junction potential.
Drugs. To avoid polysynaptic effects in response to optical stimulation of choli-
nergic fibres, glutamatergic excitatory currents were blocked by 20 μM NBQX and
50 μM AP5 in all experiments presented on Figs. 3, 5 and Supplementary Figure 3.
The following drug concentrations were used in the specified experiments (wash
application): 20 µM NBQX, 50 µM AP5, 10 µM atropine, 1 µM MLA, 1 µM DHBE,
10 µM gabazine, 1 µM CGP-55845. For puff application of ω-conotoxin (1 µM) and
ω-agatoxin (1 µM), a glass capillary was placed adjacent to the recorded cell. These
drugs were injected by mouth-applied pressure for 1–2 min during the stimulation
protocol following the control period. Drugs were dissolved in HEPES-based buffer
with a composition in mM: 126 NaCl, 10 glucose, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2,
2 MgCl2, 26 HEPES, pH 7.3. Gabazine (SR 95531 hydrobromide), CGP-55845,
MLA (Methyllycaconitine citrate), DhβE (dihydro-β-erythroidine hydrobromide)
and AFDX-116 were purchased from Tocris Bioscience, ω-conotoxin and ω-
agatoxin were purchased from Almone labs, and NBQX (2,3-Dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) and AP5 were purchased
from Hello Bio. All other salts and drugs were obtained from Sigma-Aldrich or
Molar Chemicals KFT.
Anatomical identification. The recorded cells were filled with biocytin. After the
recording, the slices were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer
(PB; pH 7.4) for at least 3 h, followed by washout with PB several times. Then,
sections were blocked with normal goat serum (NGS; 10%) diluted in Tris-buffered
saline (pH 7.4), followed by incubations in Alexa Fluor 594-conjugated streptavidin
(1:1000; Invitrogen). Sections were then mounted on slides in Vectashield (Vector
Laboratories) and were morphologically identified on the basis of their location,
dendritic and axonal arborisation.
Optogenetic illumination. For illumination, we used a blue laser diode (447 nm,
Roithner LaserTechnik GmbH) attached to a single optic fibre (Thorlabs) posi-
tioned above the hippocampal slice. In all cases, 1 ms pulse length was used. In case
of structured illumination (Supplementary Figure 3), the same laser was used with
a digital micro-mirror device (Polygon400, Mightex Systems, Toronto, Canada)
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integrated into the optical path of the microscope. We have used Polygon400 for
the illumination of the slice at a remote location (~5–600 µm), to avoid direct
illumination of ChR2-expressing terminals on the recorded cell.
Electrophysiological recordings and analysis. Both whole-cell and LFP record-
ings were performed with a Multiclamp 700A or 700B amplifier (Molecular
Devices) and were low-pass filtered at 3 kHz using the built-in Bessel filter of the
amplifier. Data were digitised at 10 kHz with a PCI-6042E board (National
Instruments) and recorded with EVAN 1.3 software (courtesy of Prof. I. Mody,
University of California Los Angeles, Los Angeles, CA). All data were analysed off-
line using custom-made programmes written in MATLAB 8.5.0, Python 2.7 by D.S.
and Delphi 6.0 by A.I.G.
The kinetic properties (20–80% rise times, decay time constant, latency) were
calculated on stimulus triggered averaged events. Fitting of a single exponential
function to the decaying phase of averaged responses and statistical analyses were
performed in OriginPro, version 9.2.214 (OriginLab Corporation, Northampton,
MA, USA). Latency from stimulation start to PSP onset was calculated as the time
when the signal crossed three times standard deviation of baseline. Transmission
probability was defined, as the probability of detectable IPSC in response to the
optical stimulation. For characterising short-term plasticity, each stimulation
frequency was repeated 20 times with an interval of 3 s. To record in parallel the
changes in cholinergic EPSP and GABAergic IPSPs (for the drug applications
presented on Fig. 5) cells were measured at −50 mV in current clamp mode. Since
the amplitude of both PSPs increased, qualitative changes in amplitude could be
measured, however in this way, we may have underestimated the changes in
amplitude due to conductances overlapping in time and acting in the opposite
directions. In the case of VDCC blocker application, we used five pulses to evoke
larger cholinergic responses. We quantified EPSP area changes for ω-agatoxin and
ω-conotoxin application after low-pass filtering (at 2 Hz) the response (e.g.
subtracting GABAergic component).
Figure 5 data were normalised for visualisation (all values were divided by the
mean of the control sample)71. LFP signals were filtered with a two way RC filter to
preserve phase. SWRs were pre-detected on 30 Hz low-pass-filtered field recordings
using a threshold value of four times the SD of the signal. The pre-detected SWRs
were then redetected using a programme that detected SWR peaks and eliminated
recording artefacts similar to SWRs. Epileptic event peaks were detected similarly.
Event rates were calculated with equal time periods for control, stimulation and
recovery phases. All automatic detection steps were manually supervised.
Perfusion. For perfusion, mice were deeply anaesthetised as above. Mice for
electron microscopical reconstruction of axonal segments and immunofluorescent
labellings were perfused transcardially first with 0.9% NaCl in 0.1 M phosphate
buffer (PBS) solution for 2 min followed by 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer (pH= 7.4; PB) for 40 min and finally with PBS for 10 min. In the
case of one WT mouse for reconstruction, the fixative also contained 0.5% glu-
taraldehyde. Two WT mice for postembedding GABA-labelling and electron
tomography were perfused first with PBS for 2 min followed by a fixative con-
taining 2% PFA and 2% glutaraldehyde in 0.1 M sodium acetate buffer (pH 6.5) for
2 min, and then by 2% PFA/2% glutaraldehyde in 0.1 M sodium borate buffer (pH
8.5) for 1 h72. Brains were removed from the skull and postfixed overnight at 4 °C
in 2% PFA/2% glutaraldehyde in 0.1 M sodium borate buffer (pH 8.5). Mice for
electron microscopical or immunfluorescent detection of gephyrin and GABAA
receptors were perfused transcardially with ice-cold, oxygenated artificial cere-
brospinal fluid [containing (mM) NaCl 125, KCl 2.5, CaCl2 2.5, MgCl2 2, NaHCO3
26, NaH2PO4 1.25, glucose 2573]. Then the brain was removed from the skull and
cut in blocks containing the hippocampal formation (separated hemispheres) and
the medial septal area. The blocks were incubated in a fixative containing 4% PFA
and 0.2% glutaraldehyde in PB for 90 min at 4 °C and then embedded in 2%
agarose for sectioning. Coronal sections were cut on a Leica VT1200S vibratome at
50 µm. All series of sections were rinsed in PB, cryoprotected sequentially in PB
containing 10 and 30% sucrose, frozen in liquid nitrogen and stored at –70 °C until
further processing.
Antibodies. We have summarised the primary antibodies used, their concentra-
tions and information on their specificity in Supplementary Table 1. The secondary
antibodies (Supplementary Table 2) were extensively tested for possible cross-
reactivity with the other secondary or primary antibodies, and possible tissue
labelling without primary antibodies was also tested to exclude auto-fluorescence or
specific background labelling by the secondary antibodies. No specific-like staining
was observed under these control conditions.
Single- and double-labelling pre-embedding immunoelectron microscopy.
Sections were freeze-thawed two times over liquid nitrogen and washed in PB.
Sections for gephyrin immunolabelling were treated with 1% sodium borohydride
in PB for 10 min. For detection of GABAA receptors, the sections were incubated in
0.2 M HCl solution containing 2 mg/ml pepsin (Dako) at 37 °C for 2–4 min. After
extensive washes in PB and 0.05 M Tris-buffered saline (pH 7.4; TBS) sections were
blocked in 1% human serum albumin (HSA; Sigma-Aldrich) in TBS. Then, they
were incubated in a mixture of primary antibodies (Supplementary Table 1) diluted
in TBS containing 0.05% sodium azide for 2–3 days. After repeated washes in TBS,
the sections were incubated in blocking solution (Gel-BS) containing 0.2% cold
water fish skin gelatine and 0.5% HSA in TBS for 1 h. Next, sections were incubated
in gold-conjugated and biotinylated secondary antibodies (Supplementary Table 1)
diluted in Gel-BS overnight. After extensive washes in TBS the sections were
treated with 2% glutaraldehyde in 0.1 M PB for 15 min to fix the gold particles into
the tissue. This was followed by incubation in avidin–biotinylated horseradish
peroxidase complex (Elite ABC; 1:300; Vector Laboratories) diluted in TBS for 3 h
at room temperature or overnight at 4 °C. The immunoperoxidase reaction was
developed using 3,3-diaminobenzidine (DAB; Sigma-Aldrich) as chromogen. To
enlarge immunogold particles, sections were incubated in silver enhancement
solution (SE-EM; Aurion) for 40–60 min at room temperature. The sections were
then treated with 1% (for electron tomography) or 0.5% OsO4 in 0.1 M PB, at room
temperature (for electron tomography) or on ice, dehydrated in ascending alcohol
series and in acetonitrile and embedded in Durcupan (ACM; Fluka). During
dehydration, the sections were treated with 1% uranyl acetate in 70% ethanol for
20 min. For electron microscopic analysis, tissue samples from the CA1 area of
dorsal hippocampus/somatosensory cortex (S1) were glued onto Durcupan blocks.
Consecutive 70 nm-thick (for conventional electron microscopic analysis) or 150
nm-thick (for electron tomography) sections were cut using an ultramicrotome
(Leica EM UC6) and picked upon Formvar-coated single-slot grids. Ultrathin
sections for conventional electron microscopic analysis were counterstained with
lead citrate (Ultrostain 2, Leica) and examined in a Hitachi 7100 electron micro-
scope equipped with a Veleta CCD camera (Olympus Soft Imaging Solutions,
Germany). 150 nm-thick electron tomography sections were examined in FEI
Tecnai Spirit G2 BioTwin TEM equipped with an Eagle 4k HS camera.
Combination of pre- and postembedding immunocytochemistry. vAChT was
visualised using the pre-embedding gold method as described above. Alternate
serial 70 nm-thick sections were mounted on copper and nickel grids (5–6 sections/
grid). Postembedding GABA immunostaining was carried out on nickel grids
according to a modified protocol74. Incubations of sections were performed on
droplets of solutions in humid Petri dishes in the following order: 0.5% periodic
acid (H5IO6) for 5 min at room temperature; three times at 2 min wash in distilled
water; 3 min in TBS; 15 min in 1% ovalbumin dissolved in TBS at 37 °C; 8 min in
TBS, 90 min rabbit anti-GABA antiserum (1:10,000 in TBS) at 37 °C; two times at
10 min TBS; 10 min in TBS containing 1% BSA and 0.05% Tween 20; 90 min at
room temperature in 10 nm colloidal gold-conjugated goat anti-rabbit IgG (BBI
solutions; 1:1000 in the same solution as before); three times at 5 min wash in
distilled water; 20 min in 10% saturated uranyl acetate; 4 wash in distilled water;
staining with lead citrate; wash in distilled water. The etching procedure of post-
embedding GABA immunostaining removes the silver precipitate of the pre-
embedding vAChT labelling (Fig. 2e); therefore, only every second electron
microscope grid was reacted for GABA and the analysis of vACHT-positive
terminals were carried out using the so called mirror technique. Sections on copper
grids adjacent to the first sections on nickel grids were systemically scanned for
pre-embedding immunogold-labelled vAChT-positive terminals. These terminals
were identified in the next, GABA-labelled section, followed in consecutive serial
sections and digital images were taken at 50,000 times magnification in each serial
section. Postembedding immunogold particles were counted on these GABA-
labelled terminals and the examined surface area was measured using the Recon-
struct software75. For comparison, we have also measured the immunogold den-
sities of putative glutamatergic terminals using the same method, in the same series
of images. Terminals forming type-I (asymmetric) synapses were considered glu-
tamatergic. Although periodic acid-etching of the sections is known to remove pre-
embedding antibodies together with immunogold and silver precipitation, we
confirmed this again in a control experiment because, here, both the pre-
embedding labelling and the postembedding GABA staining was performed using
rabbit antibodies. In these control experiments, the postembedding GABA
immunostaining was carried out without the primary anti-GABA antibody, in
which case practically no postembedding gold particles were detected, confirming
the specificity of the method.
Electron microscopy analysis of synapses of cholinergic fibres. For evaluation
of the gephyrin and GABAA receptor content at synapses of cholinergic axons, we
performed pre-embedding double labelling. vAChT (in wild-type mice) or eYFP
(in ChAT-Cre mice, see above) was labelled with DAB, while gephyrin or GABAA
γ2 subunit was labelled with immunogold (see above, Supplementary Tables 1–2).
Electron microscopic serial sections were systemically scanned for synapses of
DAB-labelled terminals. Parallel appositions between the membranes of a DAB-
containing terminal and a putative postsynaptic target were regarded as a synapse if
they displayed widening of the extracellular space at the presumptive synaptic cleft
and clustered synaptic vesicles in the terminal. Synapses found were followed and
photographed at 30,000 magnification in every section, where they were present
throughout the series: thus they were fully reconstructed. Since the background
labelling (measured in putative glutamatergic synapses in the same series of sec-
tions) was negligible, synapses containing at least one gold particle were regarded
as positive.
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3D reconstruction of axonal segments. Cholinergic axonal segments (n= 17)
were reconstructed using consecutive serial 70 nm-thick sections double labelled
for choline acetyltransferase (ChAT; DAB) and neuroligin 2 (NL2; immunogold) in
wild-type mice (n= 2) or eYFP (DAB) and gephyrin (immunogold) in ChAT-Cre
animals, in which the medial septum was injected with Cre-dependent eGFP-
containing virus (n= 2). CB1-positive axons were reconstructed from a series of 70
nm-thick sections double labelled for CB1 (DAB) and NL2 (immunogold). DAB-
containing axons were followed in consecutive serial sections and digital images
were taken at 30,000 times magnification in each serial section. Three-dimensional
reconstructions of plasma membranes, mitochondria, putative synapses of DAB-
containing axons and postsynaptic gold particles were made using the Reconstruct
software75. For preparing figures of reconstructed axons and measuring their 3D
length, Blender software (www.blender.org) was used. Postsynaptic targets of
cholinergic axons were classified as described earlier76. Briefly, spines were
recognised by their small size and specific morphology. In CA1 str. oriens and
radiatum, dendrites that have spines and do not receive type-I (asymmetric) inputs
on their shafts are known to be pyramidal cells77, whereas dendrites receiving type-
I synapses on their shafts are interneurons78. The robustness of this classification
method was reconfirmed recently76. Because in str. lacunosum-moleculare the
shafts of pyramidal dendrites may receive type-1 inputs77 they were not dis-
tinguished from interneuron dendritic shafts. Also, the dendritic shafts in soma-
tosensory cortex S1 could not be identified based on morphological features.
Immunofluorescent labelling and confocal laser-scanning microscopy. Before
the immunofluorescent staining, the 50 µm thick sections were washed in PB and
Tris-buffered saline (TBS). This was followed by blocking for 1 h in 1% human
serum albumin (HSA) and 0.1% Triton X-100 dissolved in TBS. After this, sections
were incubated in mixtures of primary antibodies overnight at room temperature.
After incubation, sections were washed in TBS, and were incubated overnight at 4 °
C in the mixture of, all diluted in TBS. Secondary antibody incubation was followed
by washes in TBS, PB, the sections were mounted on glass slides and coverslipped
with Aqua-Poly/Mount (Polysciences). Immunofluorescence was analysed using a
Nikon Eclipse Ti-E inverted microscope (Nikon Instruments Europe B.V.,
Amsterdam, The Netherlands), with a CFI Plan Apochromat VC 60XH oil
immersion objective (numerical aperture: 1.4) and an A1R laser confocal system.
We used 405, 488, 561 and 647 nm lasers (CVI Melles Griot), and scanning was
done in line serial mode. Image stacks were obtained with NIS-Elements AR
software, and deconvolved using Huygens Professional software (www.svi.nl).
STORM super-resolution microscopy. Before the immunofluorescent staining for
the super-resolution experiments, the 20 µm thick sections were washed in PB and
TBS. This was followed by blocking for 1 h in 1% HSA dissolved in TBS. After this,
sections were incubated in mixtures of primary antibodies; overnight at room
temperature. After incubation, sections were washed in TBS, and sections were
incubated overnight at 4 °C in the mixtures of secondary antibodies. Secondary
antibody incubation was followed by washing in TBS, PB; then hippocampi were
cut out with scalpels in buffer, sections were dried on clean coverslips, and stored
for maximum 3 weeks at room temperature in a dry environment before imaging.
3D direct-STORM (direct Stochastic Optical Reconstruction Microscopy) acqui-
sition protocol was used as described before79. The imaging setup was built around
a Nikon Ti-E inverted microscope equipped with a Perfect Focus System, with an
Andor iXon Ultra 897 EMCCD camera, a C2 confocal head, 405, 488 and 561 nm
lasers (Melles Griot 56RCS/S2780, Coherent Sapphire), and a high power 647 nm
laser (300 mW, MPB Communications VFL-P-300-647). A high NA ×100 oil
immersion objective (Nikon CFI SR Apochromat TIRF ×100 oil, 1.49 NA) was
used for imaging. During STORM acquisition the emitted light was let through
582/636 nm and 670/760 nm bandpass filters to reach the detector for the 561 and
647 channels, respectively. We used the NIS-Elements AR 4.3 with N-STORM
3.4 software for acquisition and analysis. Imaging medium was mixed from 80 μl
DPBS (Dulbecco’s phosphate-buffered saline), 10 μl MEA (mercaptoethylamine)
solution, 10 μl 50% glucose solution and 1 μl GLOX (glucose oxidase) solution.
Coverslips with the dried sections were mounted onto microscope slides with 25 μl
of freshly prepared imaging medium, and sealed with nail-polish. After selecting
the region of interest, confocal image stacks were acquired containing 15 focal
planes with 80 × 80 × 150 nm voxel size in x, y and z, respectively. This was fol-
lowed by bleaching the fluorophores in the STORM channels (561 and 647) with
high intensity laser illumination, and running dSTORM acquisition using oblique
(near-TIRF) illumination. The acquisition in the two channels was done in
sequential mode. Confocal stacks were deconvolved (Huygens Professional), and –
together with the STORM molecule lists – processed for further analysis in
VividSTORM software (see “Analysis”). Imaging was performed with identical
parameters (depth in the section, laser intensities, etc.) for all samples.
Electron tomography. For the electron tomographic investigation we used 150
nm-thick sections from the hippocampal CA1 region from the anti-vAChT
immunogold stained material (see: “Pre-embedding immunoelectron-micro-
scopy”). Before electron tomography, serial sections on single-slot copper grids
were photographed with a Hitachi H-7100 electron microscope and a Veleta CCD
camera. Serial sections were examined at lower magnification, and vAChT-positive
synaptic terminals from the CA1 area selected. For each terminal, the section
containing the largest synaptic cross section was chosen for electron tomography.
After this, grids were put on drops of 10% HSA in TBS for 10 min, dipped in
distilled water (DW), put on drops of 10 nm gold-conjugated Protein-A in DW
(1:3) and washed in DW. Finally, we deposited 5 and 5 nm-thick layers of carbon
on both sides of the grids. Electron tomography was performed using a Tecnai T12
BioTwin electron microscope equipped with a computer-controlled precision stage
(CompuStage, FEI). Acquisition was controlled via the Xplore3D software (FEI).
Regions of interest were pre-illuminated for 4–6 min to prevent further shrinkage.
Dual-axis tilt series were collected at 2 degree increment steps between −65 and
+65 degrees at 120 kV acceleration voltage and ×23,000 magnification with −1.6 to
−2 µm objective lens defocus. Reconstruction was performed using the IMOD
software package80. Isotropic voxel size was 0.49 nm in the reconstructed volumes.
After combining the reconstructed tomograms from the two axes, the nonlinear
anisotropic diffusion (NAD) filtering algorithm was applied to the volumes. Seg-
mentation of the terminals has been performed on the virtual sections using the
3Dmod software, and measurements were done on the scaled 3D models.
Isolation of synaptic vesicles. Synaptic vesicles were isolated according to ref. 81,
with some modifications (Supplementary Figure 4A). Briefly, cortices and hippo-
campi (neocortex and hippocampus, in 4:1 ratio) of ten C57Bl6 mice (80 days old,
mixed gender) were pulverised mechanically after freezing in liquid nitrogen. The
resulting fine powder was then homogenised using a Teflon-glass homogeniser in
0.3 M sucrose-containing HEPES buffer (0.3 M sucrose, 50 mM HEPES, pH 7.4, 2
mM EGTA). The homogenate was centrifuged at 100,000×g (1 h, 4 °C). The
supernatant was laid onto a 0.6 M/1.5 M sucrose step gradient and centrifuged at
260,000×g (2 h, 4 °C). Synaptic vesicles were collected from the 0.6 M/1.5 M sucrose
solution interface. The vesicles were either immediately used or were frozen in
liquid nitrogen and stored at −20 °C for later use.
Immunostaining and flow cytometry analysis. The vesicles were dialysed over-
night, at 4 °C, in phosphate-buffered saline (PBS; 800 ml). For dialysis a 300kD
MWCO membrane was used (Biotech CE Dialysis Tubing). All solutions used
during the dialysis or subsequent immunostaining were thoroughly filtered
through either 0.2 µm (Millipore) or 0.02 µm pore diameter filters (Anodisc-47; GE
Healthcare/Whatman). The vesicles were incubated with primary antibody in the
presence of 0.1% BSA (RT, 1 h) followed by incubation with secondary antibody
(RT, 1 h), under constant shaking. Prior to FACS analysis the stained vesicle
suspensions were dialysed again against PBS (800 ml, at RT, for 1 h). FACS analysis
was performed on a BD FACSVerse instrument.
Electron and confocal microscopy of isolated synaptic vesicles. Isolated
synaptic vesicle suspension was diluted 10× in TBS, and 100 µl was dropped onto
ultra-clean coverslips. After 10 min, 100 µl 4% PFA in 0.1 M PB was added to the
drops. For a further 15 min the coverslips were washed gently in distilled water
(DW), and processed for TEM and CLSM analysis. For the electron microscopic
investigation, vesicles fixed to the coverslips were treated with 1% OsO4 in 0.1 M
PB at room temperature, dehydrated in ascending alcohol series and in acetonitrile,
and embedded in Durcupan (ACM; Fluka). During dehydration, the coverslips
were treated with 1% uranyl acetate in 70% ethanol for 20 min. After resin poly-
merisation, small pieces were cut and removed from the coverslip surface, glued
onto plastic blocks, and 40 nm-thick sections were prepared using an ultra-
microtome (Leica EM UC6) and picked upon Formvar-coated single-slot grids.
Ultrathin sections were examined in a Hitachi 7100 electron microscope equipped
with a Veleta CCD camera (Olympus Soft Imaging Solutions, Germany). For
CLSM analysis coverslips were washed in PB and Tris-buffered saline (TBS). This
was followed by blocking for 1 h in 1% human serum albumin (HSA) dissolved in
TBS. After this, sections were incubated in mixtures of primary antibodies for 1 h at
room temperature. After incubation, sections were washed in TBS, and were
incubated for 1 h at room temperature in the mixture of secondary antibodies, all
diluted in TBS. Secondary antibody incubation was followed by washes in TBS, PB,
DW and the coverslips were mounted on glass slides with Aqua-Poly/Mount
(Polysciences). Immunofluorescence was analysed using a Nikon Eclipse Ti-E
inverted microscope (Nikon Instruments Europe B.V., Amsterdam, The Nether-
lands), with a CFI Plan Apochromat VC 60XH oil immersion objective (numerical
aperture: 1.4) and an A1R laser confocal system. The possible influence of chro-
matic aberration on PSF-position was controlled using fluorescent TetraSpeck™
Microspheres (0.1 µm diameter, blue/green/orange/dark red, ThermoFisher Sci-
entific). We used 405, 488, 561 and 647 nm lasers (CVI Melles Griot), and scanning
was done in line serial mode. Image stacks were obtained with NIS-Elements AR
software, and deconvolved using Huygens Professional software (www.svi.nl).
Statistical analysis. During segmentation of tomographic volumes, z-scaling was
calculated from the thickness difference of the reconstructed volume and the ori-
ginal section thickness, and applied to the 3D models. Mesh surface areas and
volumes inside meshed objects were measured with the “imodinfo” programme.
In STORM imaging “molecule lists” were exported from NIS in txt format, and
the three image planes of the ics-ids file pairs from the deconvolved confocal stacks
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matching the STORM-volume were converted to the ome-tiff format using Fiji
software. Confocal and corresponding STORM images were fitted in VividSTORM82.
When data populations in this work had a Gaussian distribution according to
the Shapiro–Wilks W test, we reported parametric statistical features (mean ± SD),
otherwise we reported non-parametric statistical features (median, interquartile
range). For the presentation of electrophysiological data, we used median and
interquartile range, because the data did not show Gaussian distribution. Two non-
parametric groups were compared using the Mann–Whitney U test. Wilcoxon
signed-rank test was used for calculating significance between dependent non-
parametric data groups. F-test was used to compare the variability of data groups.
The types of statistical tests used in different investigations are indicated in the text.
We always used two-tailed statistical tests. All statistical analyses were carried out
using the software package Statistica (StatSoft, Tulsa, OK, USA) or OriginPro
9.2.214 (OriginLab Corporation, Northampton, MA, USA). Adequate sample sizes
were chosen based on experience with similar measurements to ensure adequate
power to detect a specified effect size. The number of animals used was minimised
as much as possible. No animals or measurements were excluded from the
measurements after data were collected. Samples from tissue slices or from
anatomical sections were collected randomly. The investigator was not blinded to
any group allocations, because we investigated only a healthy group of mice. The
differences were considered significant at p < 0.05.
Code availability. Custom written codes for sharp wave-ripple and epileptic event
detection, and electron tomographic analysis are available upon request.
Data availability. The data generated during the current study are available from
the corresponding author on reasonable request.
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